期刊文献+

阿奇霉素序贯治疗成人社区获得性肺炎的效果分析 被引量:6

下载PDF
导出
摘要 目的:评价阿奇霉素序贯治疗成人社区获得性肺炎(CAP)的临床疗效与安全性。方法:选择132例住院CAP患者,随机分为观察组和对照组,观察组以阿奇霉素粉针剂500mg加入5%葡萄糖500ml静脉滴注,每日1次,连用5日,继以阿奇霉素片剂500mg每日1次口服,总疗程10日。对照组予加替沙星氯化钠注射液200ml静脉滴注,每日1次,连用5日,继以加替沙星片0.4每日1次口服,总疗程10日。结果:观察组有效率为80.8%,对照组为76.0%,观察组不良反应发生率为14.7%,低于对照组的25%。结论:阿奇霉素序贯治疗成人CAP疗效好且不良反应发生率低。
出处 《交通医学》 2008年第3期257-258,共2页 Medical Journal of Communications
  • 相关文献

参考文献8

  • 1Schentag JJ, Ballow CH. Tissue-directed pharmacokingtics [J]. Am J Med, 1991,91(3A):5S-11s.
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:787
  • 3Niedeman MS, Mandell LA, Anzueto A, et al. Guidelines for the Managemenf of Adults with Community-acquired Pneumonia [J]. Am J Respir Crit Care Med,2001,163 (7):1730- 1754.
  • 4Heffelfinger JD, Dowell SF, Jorgensen JH, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group [J]. Arch Intern Med, 2000, 160(10) : 1399-1408.
  • 5黄海辉,吴菊芳,张婴元,修清玉,周新,黄绍光,刘又宁,周乐,汪复.阿奇霉素序贯疗法治疗社区获得性肺炎138例临床评价[J].中国抗感染化疗杂志,2004,4(5):257-262. 被引量:9
  • 6Hoban D J, Zhanel GG. Clinical implications of macrolide resisitance in community-acquired respiratory tract infections [J]. Expert Rev Anti hffect Ther,2006,4(6):973-980.
  • 7Swainston Harrison T, Keam SJ. Azithromycin extended release: a review of its use in the treatment of acute bacterial sinusitis and community-acquired pneumonia in the US [J]. Drugs, 2007,67(5):773-792.
  • 8Zervos M, Martinez FJ, Amsden GW, et al. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchi- tis[J]. Int J Antimicrob Agents,2007,29(1):56-61.

二级参考文献23

  • 1Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 2Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
  • 3Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
  • 4Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
  • 5Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
  • 6[1]Dowell SF, Peeling RW, Boman J, et al. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention(USA) and the Laboratory Centre for Disease Control(Canada). Clin Infect Dis, 2001,33: 492-503
  • 7[2]Hindiyeh M,Carroll KC. Laboratory diagnosis of atypical pneumonia. Semin Respir Infect,2000,15: 101-113
  • 8[3]File TJ Jr. Community-acquired pneumonia: new guidelines for management. Curr Opin Infect Dis,2001,14: 161-164
  • 9[4]Dalhoff K. Worldwide guidelines for respiratory tract infections: community-acquired pneumonia. Int J Antimicrob Agent, 2001,18 : S39-S44
  • 10[6]Wang MG, Zhang YY, Zhu DM, et al. Prevalence and phenotypes of erythromycin-resistant Streptococcus pneumoniae in Shanghai, China. Diagn Microbiol Infect Dis, 2001,39:187-189

共引文献792

同被引文献23

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部